EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,602 | +69.9% | 1,370 | +109.5% | 0.00% | – |
| Q2 2023 | $12,712 | +797.1% | 654 | +1208.0% | 0.00% | – |
| Q1 2023 | $1,417 | +41.7% | 50 | -5.7% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 53 | -5.4% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 56 | -42.9% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 98 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -70.6% | 98 | -70.1% | 0.00% | – |
| Q4 2021 | $17,000 | -10.5% | 328 | -3.8% | 0.00% | – |
| Q3 2021 | $19,000 | +35.7% | 341 | 0.0% | 0.00% | – |
| Q2 2021 | $14,000 | -17.6% | 341 | -20.5% | 0.00% | – |
| Q1 2021 | $17,000 | -15.0% | 429 | +4.6% | 0.00% | – |
| Q4 2020 | $20,000 | +33.3% | 410 | -0.2% | 0.00% | – |
| Q3 2020 | $15,000 | +25.0% | 411 | +58.1% | 0.00% | – |
| Q2 2020 | $12,000 | +9.1% | 260 | +18.7% | 0.00% | – |
| Q1 2020 | $11,000 | – | 219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |